New drug ISM4808 put to the test in healthy volunteers
Knowledge-focused
Not yet recruiting
This early-stage study tests the safety and tolerability of a new oral drug called ISM4808 in 86 healthy adults aged 18-55 in China. Participants receive either the drug or a placebo, and researchers monitor for side effects and how the drug moves through the body. The goal is to…
Phase: PHASE1 • Sponsor: TaiGen Biotechnology Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC